Becoming CEO

Andy Fish is the executive director of AdvaMedDx, an organization that advocates for the power of medical diagnostic tests to promote wellness, improve patient outcomes, and advance public health in the United States and abroad. His advocacy organization represents over 75 member companies that produce innovative diagnostic tests performed in laboratories, at the hospital bedside, in doctor’s offices, in medical clinics, and in the home. These tests facilitate evidence-based medicine, improve quality of care, promote wellness, and enable early detection of disease. And, since they ultimately influence as much as 70% of health care decision making, they often reduce health care costs. As technology advances, a new generation of diagnostics testing that provides insights at the molecular level is delivering on the promise of personalized medicine. Andy Fish works daily with legislators and company leaders to make sure that the industry keeps moving in that direction. http://bit.ly/becomingceo

Diagnostics: The intersection of Investment, Access and Innovation A discussion with Ajit Singh of Artiman Ventures, Trevor Hawkins, Ph.D. of Siemens Healthcare Diagnostics and Ken Song, M.D. of Ariosa Diagnostics http://bit.ly/becomingceo

In this series, CEOs in the cutting-edge diagnostics industry share how their careers developed and the goals and aspirations that motivate them. Ms. Palmieri was appointed President and CEO in January 2015. She joined Vermillion as Chief Operating Officer in October 2014. Ms. Palmieri brings to Vermillion more than 30 years of experience in the diagnostic laboratory industry, serving in numerous sales, operations, and executive leadership positions for both laboratory service and consulting organizations. Prior to Vermillion, Valerie was CEO/President of MOMENTUM Consulting. Prior to MOMENTUM, Ms. Palmieri served as CEO/President of two healthcare start-ups that resulted in a successful exit for one and won her recognition as one of the “Top 10 Entrepreneurs of Springboard Enterprises” for the other. She also spent six years as National Vice President of Anatomic Pathology Operations with LabCorp, the successor company to DIANON Systems where she served as Senior Vice President of Operations. She was a key leader in the sale of DIANON to LabCorp in 2003. Ms. Palmieri holds a Bachelor of Science degree in Medical Technology from Western Connecticut State University. http://bit.ly/becomingceo